Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  DaVita Inc.    DVA

DAVITA INC.

(DVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • With a P/E ratio at 13.48 for the current year and 12.69 for next year, earnings multiples are highly attractive compared with competitors.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 69.7 USD
Weaknesses
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • The company is in debt and has limited leeway for investment
Ratings chart
Sector Healthcare Facilities & Services - NEC
1st jan.Capitalisation (M$)Investor Rating
DAVITA INC.9.28%9 977
CVS HEALTH CORPORATION-13.96%82 530
HCA HEALTHCARE, INC.-35.30%32 286
FRESENIUS MEDICAL CARE AG &..14.46%25 020
PING AN HEALTHCARE AND TECH..126.39%17 077
LABORATORY CORPORATION OF A..3.13%16 958
QUEST DIAGNOSTICS10.42%15 770
UNIVERSAL HEALTH SERVICES-36.78%7 703
CHEMED CORPORATION8.40%7 558
WINNING HEALTH TECHNOLOGY G..122.16%7 355
ENCOMPASS HEALTH CORPORATIO..-11.30%6 107
RYMAN HEALTHCARE LIMITED-21.92%4 250
JINXIN FERTILITY GROUP LIMI..6.72%3 498
DIAN DIAGNOSTICS GROUP CO.,..57.25%3 087
KORIAN SA-21.95%3 063
BUMRUNGRAD HOSPITAL-17.01%3 051
More Results
Financials (USD)
Sales 2020 11 697 M - -
Net income 2020 763 M - -
Net Debt 2020 7 015 M - -
P/E ratio 2020 13,5x
Yield 2020 -
Capitalization 9 977 M 9 977 M -
EV / Sales 2019
EV / Sales 2020 1,45x
Nbr of Employees 65 000
Free-Float 94,1%
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes